UPSC MainsANI-HUSB-VETER-SCIENCE-PAPER-I202315 Marks
हिंदी में पढ़ें
Q13.

Enlist hemorrhagic disorders in animals and describe congenital thrombocytopenia in dogs.

How to Approach

This question requires a structured response. First, I'll list the common hemorrhagic disorders in animals, categorizing them as infectious, toxic, and congenital. Subsequently, I'll dedicate a significant portion to describing congenital thrombocytopenia in dogs, covering its etiology, clinical signs, diagnosis, and management. The answer will be tailored for a UPSC Mains audience, emphasizing clarity, detail, and relevant terminology. A table will be used to organize hemorrhagic disorders for better comprehension.

Model Answer

0 min read

Introduction

Hemorrhagic disorders in animals encompass a diverse range of conditions characterized by impaired blood clotting, leading to excessive bleeding. These disorders can arise from various etiologies, including infectious agents, toxic exposures, and inherited genetic defects. Understanding the underlying mechanisms and specific manifestations of these conditions is crucial for effective diagnosis and treatment in veterinary medicine. The prevalence of hemorrhagic disorders varies depending on species, geographical location, and exposure to risk factors. This response will outline common hemorrhagic disorders and subsequently detail congenital thrombocytopenia, a significant concern in canine populations.

Hemorrhagic Disorders in Animals: An Overview

Hemorrhagic disorders are broadly categorized into infectious, toxic, and congenital types. Each category presents unique challenges in diagnosis and management.

1. Infectious Hemorrhagic Disorders

  • Canine Distemper Virus (CDV): CDV can cause thrombocytopenia due to bone marrow suppression.
  • Canine Parvovirus (CPV): Similar to CDV, CPV infection can lead to thrombocytopenia.
  • Leptospirosis: This bacterial infection can cause disseminated intravascular coagulation (DIC), a life-threatening condition involving widespread clotting and bleeding.
  • African Swine Fever (ASF): A viral disease affecting pigs, ASF causes severe hemorrhagic fever with high mortality rates.

2. Toxic Hemorrhagic Disorders

  • Rodenticides (Anticoagulants): These poisons interfere with the vitamin K cycle, inhibiting the synthesis of clotting factors.
  • Snake Envenomation: Venom from certain snakes contains toxins that disrupt the coagulation cascade.
  • Drug-induced: Certain medications, such as non-steroidal anti-inflammatory drugs (NSAIDs), can impair platelet function.

3. Congenital Hemorrhagic Disorders

  • Von Willebrand Disease (vWD): A deficiency or dysfunction of von Willebrand factor (vWF), a protein essential for platelet adhesion and coagulation.
  • Hemophilia A & B: Deficiencies in clotting factors VIII (Hemophilia A) and IX (Hemophilia B), respectively.
  • Thrombocytopenia Congenita: A rare inherited disorder characterized by low platelet count. This will be discussed in detail below.

Congenital Thrombocytopenia in Dogs: A Detailed Description

Congenital thrombocytopenia in dogs refers to a significantly reduced platelet count present from birth. It is a relatively rare condition, but can have devastating consequences if not diagnosed and managed appropriately.

Etiology and Genetics

The most common form is Bernard-Soulier Syndrome (BSS), an autosomal recessive disorder affecting the GPIIb/IIIa receptor complex on platelets. This receptor is crucial for platelet aggregation. Other genetic causes are being investigated, but remain less well-defined. Inheritance patterns are important to understand for breeding decisions.

Clinical Signs

  • Bruising (Ecchymosis): Easy bruising, often noticed shortly after birth.
  • Petechiae: Small, pinpoint red or purple spots on the skin and mucous membranes.
  • Bleeding from Mucous Membranes: Bleeding from the nose (epistaxis), gums, or eyes.
  • Hemarthrosis: Bleeding into joints, causing lameness and swelling.
  • Intracranial Hemorrhage: A serious complication that can lead to neurological signs and death.

Diagnosis

  • Complete Blood Count (CBC): A low platelet count (<100,000/µL is considered thrombocytopenic, but affected dogs may have even lower counts) is the hallmark of thrombocytopenia.
  • Peripheral Blood Smear: Examination of the blood under a microscope to assess platelet morphology. In BSS, platelets are often abnormally large.
  • Platelet Function Assays: Tests to evaluate platelet aggregation and adhesion. These are often abnormal in BSS.
  • Genetic Testing: DNA testing can confirm the presence of mutations in genes associated with platelet disorders, particularly for BSS. This is becoming increasingly available.

Management

Management focuses on minimizing bleeding risks and providing supportive care.

  • Avoidance of Trauma: Protecting the dog from injuries is paramount.
  • Medications: Avoidance of NSAIDs and other drugs that impair platelet function.
  • Platelet Transfusions: May be necessary in cases of severe bleeding or before surgical procedures.
  • Splenectomy: In some cases, surgical removal of the spleen may be considered, although its effectiveness is variable.
  • Genetic Counseling: For breeders, genetic counseling is crucial to prevent the propagation of affected genes.
Disorder Etiology Common Affected Species Key Clinical Signs
Canine Distemper Viral Infection Dogs Thrombocytopenia, neurological signs
Rodenticide Poisoning Toxic Exposure Dogs, Cats Bleeding, bruising, lethargy
Bernard-Soulier Syndrome Genetic (Autosomal Recessive) Dogs (particularly Doberman Pinschers) Severe thrombocytopenia, bruising, bleeding
In conclusion, hemorrhagic disorders in animals represent a significant veterinary challenge, with diverse causes ranging from infectious diseases to genetic predispositions. Congenital thrombocytopenia in dogs, particularly Bernard-Soulier Syndrome, requires careful diagnosis and ongoing management to minimize bleeding risks. Advancements in genetic testing are crucial for accurate diagnosis and responsible breeding practices. Further research into the pathogenesis of these disorders is essential for developing more effective therapeutic interventions and improving the quality of life for affected animals.

Conclusion

In conclusion, hemorrhagic disorders in animals represent a significant veterinary challenge, with diverse causes ranging from infectious diseases to genetic predispositions. Congenital thrombocytopenia in dogs, particularly Bernard-Soulier Syndrome, requires careful diagnosis and ongoing management to minimize bleeding risks. Advancements in genetic testing are crucial for accurate diagnosis and responsible breeding practices. Further research into the pathogenesis of these disorders is essential for developing more effective therapeutic interventions and improving the quality of life for affected animals.

Answer Length

This is a comprehensive model answer for learning purposes and may exceed the word limit. In the exam, always adhere to the prescribed word count.

Additional Resources

Key Definitions

Thrombocytopenia
A condition characterized by a lower-than-normal platelet count in the blood.
Disseminated Intravascular Coagulation (DIC)
A life-threatening condition involving widespread clotting and subsequent bleeding, often triggered by sepsis or other severe illnesses.

Key Statistics

The prevalence of Bernard-Soulier Syndrome in Doberman Pinschers is estimated to be around 1 in 500 dogs. (Source: Knowledge Cutoff)

Source: Knowledge Cutoff

The mortality rate for African Swine Fever (ASF) can exceed 100% in susceptible pig populations. (Source: OIE)

Source: World Organisation for Animal Health (OIE)

Examples

Case Study: Doberman Pinscher with BSS

A 6-month-old Doberman Pinscher puppy presented with recurrent nosebleeds and easy bruising. A CBC revealed a platelet count of 15,000/µL. A peripheral blood smear showed abnormally large platelets. Genetic testing confirmed a mutation in the GPIIb/IIIa gene, consistent with Bernard-Soulier Syndrome. The puppy required platelet transfusions prior to a dental procedure and was managed with strict avoidance of trauma and NSAIDs.

Frequently Asked Questions

Can hemorrhagic disorders be prevented?

While not all hemorrhagic disorders are preventable, genetic screening and responsible breeding practices can significantly reduce the risk of congenital conditions. Vaccination and preventative measures against infectious diseases are also crucial.

What is the role of genetics in hemorrhagic disorders?

Genetics play a significant role in congenital hemorrhagic disorders. Identifying affected genes and understanding inheritance patterns is crucial for diagnosis, genetic counseling, and breeding decisions.

Topics Covered

Veterinary MedicineAnimal HealthBlood DisordersThrombocytopeniaDog Diseases